0 Commentaires
0 Parts
483 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Clinical Recognition and Data Sharing: Key Aicardi Syndrome Market trends in Rare Disease Management and DiagnosisThe primary Aicardi Syndrome Market trends are characterized by the increasing technological sophistication of diagnostics and a global movement toward collaborative rare disease management. A key trend is the wider and faster adoption of next-generation sequencing (NGS) technology in pediatric neurology. NGS, particularly whole-exome and whole-genome sequencing, is increasingly becoming...0 Commentaires 0 Parts 797 Vue 0 Aperçu
-
Cystic Fibrosis Market Dynamics Reflecting Growing Rare Disease AwarenessPolaris Market Research has introduced the latest market research report titled Cystic Fibrosis Market Size, Share, Trends, & Industry Analysis Report By Therapy Class, By Route of Administration, By Distribution Channel, and By Region – Market Forecast, 2026-2034 that highlights the major revenue stream for the forecast period. The report contains clear, reliable, and...0 Commentaires 0 Parts 225 Vue 0 Aperçu
-
Gene Therapy for Rare Disease Market to Grow at a CAGR of 35.5% Through 2032“According to a new report published by Introspective Market Research, Gene Therapy for Rare Disease Market by Therapy Type, Vector Type, and Indication, The Global Gene Therapy for Rare Disease Market Size Was Valued at USD 101.5 Billion in 2023 and is Projected to Reach USD 2,869.54 Billion by 2032, Growing at a CAGR of 35.5% from 2024–2032.” Gene therapy for rare diseases...0 Commentaires 0 Parts 432 Vue 0 Aperçu
-
Growing Commercial Demand Fuels the U.S Rare Disease Diagnostics MarketPolaris Market Research has published a new report titled U.S. Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Gastroenterology Disease, Endocrine and Metabolism Disorders Disease, Cardiovascular Disorders, Musculoskeletal Disorders, Neurology Disease, Hematology and Oncology Disease, Dermatology Disease, And Others), By Product Type, By...0 Commentaires 0 Parts 553 Vue 0 Aperçu
-
Gynandroblastoma Market Trends, Rare Disease Treatment Insights & Future OpportunitiesThe Gynandroblastoma Market refers to the clinical landscape surrounding the diagnosis, treatment, and supportive care of gynandroblastoma, a rare ovarian tumor featuring both male (Sertoli/Leydig) and female (granulosa) cell components. Although gynandroblastoma accounts for a very small proportion of ovarian neoplasms, specialized diagnostic tools, therapeutic strategies, and...0 Commentaires 0 Parts 223 Vue 0 Aperçu
-
Hereditary Angioedema Therapeutic Market – Rare Disease Innovation, Targeted Biologics & Treatment Accessibility"Executive Summary Hereditary Angioedema Therapeutic Market: Growth Trends and Share Breakdown CAGR Value The global hereditary angioedema therapeutic market size was valued at USD 4.25 billion in 2024 and is expected to reach USD 8.29 billion by 2032, at a CAGR of 8.72% during the forecast period The Hereditary Angioedema Therapeutic Market report has been formed with the appropriate...0 Commentaires 0 Parts 420 Vue 0 Aperçu
-
How Are Rare Disease Research and Targeted Therapies Expanding the AL Amyloidosis Market?Executive Summary Systemic Light Chain (AL) Amyloidosis Market: Growth Trends and Share Breakdown CAGR Value The global systemic light chain (AL) amyloidosis market size was valued at USD 2.59 billion in 2025 and is expected to reach USD 3.68 billion by 2033, at a CAGR of 4.50% during the forecast period The key highlights of this Systemic Light Chain (AL) Amyloidosis Market report are key...0 Commentaires 0 Parts 188 Vue 0 Aperçu
-
How Patient Advocacy Is Influencing Rare Disease Research and DevelopmentAwareness surrounding ataxia telangiectasia has grown significantly in recent years as advancements in genetic research and rare disease advocacy continue to influence healthcare priorities. This complex condition, which affects neurological and immune systems, demands extensive therapeutic innovation. Emerging studies are helping scientists better understand how DNA repair defects contribute...0 Commentaires 0 Parts 750 Vue 0 Aperçu
-
Niemann-Pick Disease Type C Drugs Market – Rare Neurodegenerative Therapies, Orphan Drug Development & Research Funding"Regional Overview of Executive Summary Niemann-pick Disease Type C Drugs Market by Size and Share CAGR Value The global Niemann-pick Disease Type C Drugs market size was valued at USD 708.75 million in 2024 and is projected to reach USD 2024.61 million by 2032, with a CAGR of 14.02% during the forecast period of 2025 to 2032 A consistent market research report like Niemann-pick...0 Commentaires 0 Parts 472 Vue 0 Aperçu
-
Organ-on-Chip Market: Disease Modeling Capabilities Advance Rare Condition ResearchA new growth forecast report titled Organ-on-a-Chip Market Size, Share, Trends, Industry Analysis Report By Product & Services (Products, Services), By Application, By End Use, By Region – Market Forecast, 2025–2034 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of growth factors,...0 Commentaires 0 Parts 365 Vue 0 Aperçu
-
Orphan Drug Development Fuels Demand in Rare Disease Genetic Testing MarketPolaris Market Research has announced the latest report, namely Rare Disease Genetic Testing Market Size, Share, Trends, Industry Analysis Report: By Technology, Speciality (Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical Genetic Tests), Disease Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market...0 Commentaires 0 Parts 433 Vue 0 Aperçu
-
Acquired Methemoglobinemia Market Sees Research Momentum and Drug Innovation Globally Through 2032"Executive Summary Acquired Methemoglobinemia Market : CAGR Value The global acquired methemoglobinemia market size was valued at USD 1.93 billion in 2024 and is projected to reach USD 2.81 billion by 2032, with a CAGR of 4.80% during the forecast period of 2025 to 2032. This global Acquired Methemoglobinemia Market research report is organized by collecting market research data...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Andersen Disease Treatment Market Analysis: Industry Size, Growth Trends, Key Players, and Strategic Outlook"Executive Summary Andersen Disease Treatment Market: Share, Size & Strategic Insights The global andersen disease treatment market size was valued at USD 1.27 billion in 2025 and is expected to reach USD 2.05 billion by 2033, at a CAGR of 6.20% during the forecast period The Andersen Disease Treatment report provides CAGR values along with its...0 Commentaires 0 Parts 311 Vue 0 Aperçu
-
Bullous Pemphigoid Treatment Market Sees Growth in Targeted Therapies and Advanced Dermatological Care"Executive Summary Bullous Pemphigoid Treatment Market : CAGR Value The global bullous pemphigoid treatment market size was valued at USD 1.93 billion in 2024 and is projected to reach USD 2.76 billion by 2032, with a CAGR of 4.60% during the forecast period of 2025 to 2032. For drawing up sustainable, money-making, and profitable business strategies, Bullous Pemphigoid Treatment...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Cushing's Disease Market Overview, Growth Analysis, Trends and Forecast By 2029"Executive Summary Cushing's Disease Market : Data Bridge Market Research analyses that the Cushing's disease market was valued at USD 333.80 million in 2021 and is expected to reach USD 686.89 million by 2029, registering a CAGR of 9.44% during the forecast period of 2022 to 2029. The Cushing's Disease Market report highlights the global key manufacturers to define, describe and...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Ankylosing Hyperostosis Market Gains Clinical Attention with Better Imaging and Treatment Modalities"Executive Summary Ankylosing Hyperostosis Market : CAGR Value The global ankylosing hyperostosis market size was valued at USD 6.01 billion in 2024 and is projected to reach USD 8.23 billion by 2032, with a CAGR of 4.00% during the forecast period of 2025 to 2032. The Ankylosing Hyperostosis Market report has been designed in such a way that it proves to be the most appropriate...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Rett Syndrome Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Rett Syndrome Market : The global Rett syndrome market size was valued at USD 35.34 billion in 2024 and is projected to reach USD 3,130.02 billion by 2032, with a CAGR of 75.15% during the forecast period of 2025 to 2032 Comprehensive data and brilliant forecasting techniques used in Rett Syndrome Market report coincide with precision and correctness....0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
How Is the Essential Thrombocytosis Treatment Market Advancing Rare Blood Disorder Care?Detailed Analysis of Executive Summary Essential Thrombocytosis Treatment Market Size and Share CAGR Value The global essential thrombocytosis treatment market size was valued at USD 968.50 Million in 2025 and is expected to reach USD 1509.03 Million by 2033, at a CAGR of 5.70% during the forecast period The Essential Thrombocytosis Treatment report provides market shares at global...0 Commentaires 0 Parts 344 Vue 0 Aperçu
-
Idiopathic Pulmonary Fibrosis Market to Hit USD 7.40 Billion by 2032“According to a new report published by Introspective Market Research, Idiopathic Pulmonary Fibrosis Market by Drug Class, Route of Administration, and Distribution Channel, The Global Idiopathic Pulmonary Fibrosis Market Size Was Valued at USD 4.03 Billion in 2023 and is Projected to Reach USD 7.40 Billion by 2032, Growing at a CAGR of 6.99% From 2024–2032.” Idiopathic...0 Commentaires 0 Parts 386 Vue 0 Aperçu
-
Neurofibromatosis Drugs Market Outlook 2026–2034: 14.1% CAGR Forecast, Emerging Treatment Trends & Growth AnalysisNeurofibromatosis drugs are pharmaceutical treatments that help control tumor growth and manage complications caused by the condition. These medications support symptom management and improve patient care. Neurofibromatosis Drugs Market Size and Growth Outlook (2026–2034) The global Neurofibromatosis Drugs Market size is projected to reach US$ 12.34 billion by 2034 from US$...0 Commentaires 0 Parts 287 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek